Le Lézard
Classified in: Health
Subject: MRR

The Worldwide Ultrasound Device Industry is Expected to Reach $13.56 Billion by 2028


DUBLIN, Jan. 21, 2022 /PRNewswire/ -- The "Ultrasound Device Market Size, Share & Trends Analysis Report Analysis by Product (Diagnostic, Therapeutic), by Portability (Handheld, Cart/Trolley), by Application, by End-use, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global ultrasound device market size is expected to reach USD 13.56 billion by 2028. The market is expected to expand at a CAGR of 4.8% from 2021 to 2028. Ultrasound is a very efficient technology that aids in the diagnosis of various disorders such as tumors as well as the detection of changes in the appearance of organs, tissues, and arteries. It also has a range of therapeutic applications. An increase in the adoption of ultrasound devices for diagnosis and treatment is driving the market. In addition, a rise in the adoption of minimally invasive surgeries, coupled with technological advancements, is expected to boost market growth.

Emerging innovations in ultrasound technology are expanding the market size. Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities around the world. Furthermore, the introduction of 3D/4D ultrasound and the integration of artificial intelligence (Al) to automate time-consuming processes are expected to propel market growth during the forecast period. For instance, in September 2020, GE Healthcare launched Voluson SWIFT, a new ultrasound technology, which is designed to help women's health by allowing clinicians to enhance patient outcomes by expanding diagnostic capabilities. The system includes industry-first AI algorithms for auto-recognition and has excellent image quality.

The rising prevalence of chronic diseases like cancer, neurological conditions, orthopedic conditions, and cardiovascular diseases, which demand the adoption of ultrasound devices for diagnosis, is expected to expand the market during the forecast period. In addition, the market for therapeutic ultrasound equipment is predicted to grow due to the rising use of ultrasound techniques for various therapeutic procedures using High-Intensity Focused Ultrasound (HIFU) technology and Extracorporeal Shockwave Lithotripsy (ESWL).

The market's prominent competitors are taking different initiatives such as acquisitions and funding of medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, in September 2021, GE Healthcare acquired BK Medical, a leader in advanced surgical visualization.

Ultrasound Device Market Report Highlights

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Ultrasound Device Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing adoption of ultrasound devices for diagnosis and treatment
3.4.1.2. Rising demand for minimally invasive surgical procedures
3.4.1.3. Technological advancements
3.4.2. Market restraint analysis
3.4.2.1. Lack of skilled professionals
3.4.2.2. Limitations of ultrasound imaging
3.5. Ultrasound Device Market Analysis Tools
3.5.1. Industry Analysis - Porter's
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Ultrasound Device Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Diagnostic ultrasound devices
4.1.1.1. 2D
4.1.1.2. 3D/4D
4.1.1.3. Doppler
4.1.2. Therapeutic ultrasound devices
4.1.2.1. High-intensity focused ultrasound
4.1.2.2. Extracorporeal shockwave lithotripsy
4.2. Product Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. Global Ultrasound Device Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2028 for the following
4.5.1. Diagnostic ultrasound devices
4.5.1.1. Diagnostic ultrasound devices market estimates and forecast 2017 to 2028 (USD Million)
4.5.1.2. 2D
4.5.1.3. 2D market estimates and forecast 2017 to 2028 (USD Million)
4.5.1.4. 3D/4D
4.5.1.5. 3D/4D market estimates and forecast 2017 to 2028 (USD Million)
4.5.1.6. Doppler
4.5.1.7. Doppler market estimates and forecast 2017 to 2028 (USD Million)
4.5.2. Therapeutic ultrasound devices
4.5.2.1. Therapeutic ultrasound devices market estimates and forecast 2017 to 2028 (USD Million)
4.5.2.2. High-intensity focused ultrasound
4.5.2.3. High-intensity focused ultrasound market estimates and forecast 2017 to 2028 (USD Million)
4.5.2.4. Extracorporeal shockwave lithotripsy
4.5.2.5. Extracorporeal shockwave lithotripsy ultrasound market estimates and forecast 2017 to 2028 (USD Million)

Chapter 5. Ultrasound Device Market: Portability Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Handheld
5.1.2. Cart/Trolley
5.2. Portability Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Ultrasound Device Market by Portability Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2028 for the following
5.5.1. Handheld
5.5.1.1. Handheld market estimates and forecast 2017 to 2028 (USD Million)
5.5.2. Cart/Trolley
5.5.2.1. Cart/Trolley market estimates and forecast 2017 to 2028 (USD Million)

Chapter 6. Ultrasound Device Market: Application Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Cardiology
6.1.2. Obstetrics/gynecology
6.1.3. Vascular
6.1.4. Orthopedics
6.1.5. General imaging
6.2. Application Market Share, 2020 & 2028
6.3. Segment Dashboard
6.4. Global Ultrasound Device Market by Application Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2028 for the following
6.5.1. Cardiology
6.5.1.1. Cardiology estimates and forecast 2017 to 2028 (USD Million)
6.5.2. Obstetrics/gynecology
6.5.2.1. Obstetrics/gynecology market estimates and forecast 2017 to 2028 (USD Million)
6.5.3. Vascular
6.5.3.1. Vascular market estimates and forecast 2017 to 2028 (USD million)
6.5.4. Orthopedics
6.5.4.1. Orthopedics market estimates and forecast 2017 to 2028 (USD Million)
6.5.5. General imaging
6.5.5.1. General imaging market estimates and forecast 2017 to 2028 (USD Million)

Chapter 7. Ultrasound Device Market: End-use Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Hospitals
7.1.2. Imaging centers
7.1.3. Research centers
7.2. End-use Market Share, 2020 & 2028
7.3. Segment Dashboard
7.4. Global Ultrasound Device Market by End-use Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2017 to 2028 for the following
7.5.1. Hospitals
7.5.1.1. Hospitals estimates and forecast 2017 to 2028 (USD Million)
7.5.2. Imaging centers
7.5.2.1. Imaging centers market estimates and forecast 2017 to 2028 (USD Million)
7.5.3. Research centers
7.5.3.1. Research centers market estimates and forecast 2017 to 2028 (USD million)

Chapter 8. Ultrasound Device Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2020
9.3.4. Koninklijke Philips N.V.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. GE Healthcare
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Siemens Healthineers AG
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Canon Medical Systems
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Mindray Medical International Limited
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Samsung Medison Co., Ltd.
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. FUJIFILM SonoSite, Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Konica Minolta Inc.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Esaote
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives

For more information about this report visit https://www.researchandmarkets.com/r/w9pjry

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:20
The "Global Antibiotics Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Antibiotics Partnering Terms and Agreements 2010 to 2022 report provides an understanding and access to the...

at 07:15
Aurora Spine Corporation ("Aurora Spine" or the "Company") , a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press release for the first quarter...

at 07:15
Biohaven Pharmaceutical Holding Company Ltd. today announced top-line results from a Phase 3 clinical trial evaluating the efficacy and safety of its investigational therapy, troriluzole, in patients with spinocerebellar ataxia (SCA). The primary...

at 07:10
ICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, has been recognised with a number of prestigious business and industry awards...

at 07:10
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced new positive results from an 18-month analysis of exploratory cardiac endpoints in the HELIOS-A Phase 3 study of vutrisiran, an investigational RNAi therapeutic in...

at 07:10
The "Global Electronic Pipettes Market Size & Share to 2027" report has been added to ResearchAndMarkets.com's offering. Electronic Pipettes are used in pharmaceutical, biotechnology, and chemical laboratories in order to transfer certain volume of...



News published on 21 january 2022 at 09:30 and distributed by: